Total Payments
$94,671
2021 Payments
$30.43
Companies
6
Transactions
107
Medicare Patients
1,490
Medicare Billing
$513,166
Payment Breakdown by Category
Consulting$44,548 (47.1%)
Other$40,893 (43.2%)
Travel$6,490 (6.9%)
Food & Beverage$2,740 (2.9%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $44,548 | 13 | 47.1% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $40,893 | 18 | 43.2% |
| Travel and Lodging | $6,490 | 43 | 6.9% |
| Food and Beverage | $2,740 | 33 | 2.9% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| TELA Bio, Inc. | $50,071 | 47 | $0 (2020) |
| Merck Sharp & Dohme Corporation | $25,360 | 34 | $0 (2020) |
| La Jolla Pharmaceutical Company | $19,140 | 21 | $0 (2018) |
| Integra LifeSciences Corporation | $53.64 | 2 | $0 (2021) |
| Intuitive Surgical, Inc. | $25.00 | 2 | $0 (2018) |
| Allergan Inc. | $21.10 | 1 | $0 (2018) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2021 | $30.43 | 1 | Integra LifeSciences Corporation ($30.43) |
| 2020 | $10,690 | 12 | Merck Sharp & Dohme Corporation ($8,417) |
| 2019 | $24,945 | 26 | TELA Bio, Inc. ($16,087) |
| 2018 | $51,266 | 59 | TELA Bio, Inc. ($26,654) |
| 2017 | $7,739 | 9 | TELA Bio, Inc. ($5,079) |
All Payment Transactions
107 individual payment records from CMS Open Payments — Page 1 of 5
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 05/07/2021 | Integra LifeSciences Corporation | SURGIMEND (Device) | Food and Beverage | In-kind items and services | $30.43 | General |
| Category: RECON-SKIN AND WOUND | ||||||
| 11/14/2020 | TELA Bio, Inc. | Ovitex (Device) | Consulting Fee | Cash or cash equivalent | $2,250.00 | General |
| Category: Surgical Mesh | ||||||
| 09/21/2020 | Integra LifeSciences Corporation | SURGIMEND (Device) | Food and Beverage | In-kind items and services | $23.21 | General |
| Category: RECON-SKIN AND WOUND | ||||||
| 03/27/2020 | Merck Sharp & Dohme Corporation | ZERBAXA (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,520.00 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 03/19/2020 | Merck Sharp & Dohme Corporation | ZERBAXA (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,520.00 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 03/06/2020 | Merck Sharp & Dohme Corporation | ZERBAXA (Drug) | Travel and Lodging | Cash or cash equivalent | $75.00 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 03/03/2020 | Merck Sharp & Dohme Corporation | ZERBAXA (Drug) | Travel and Lodging | Cash or cash equivalent | $150.00 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 02/28/2020 | Merck Sharp & Dohme Corporation | ZERBAXA (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,520.00 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 02/28/2020 | Merck Sharp & Dohme Corporation | ZERBAXA (Drug) | Travel and Lodging | Cash or cash equivalent | $150.00 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 02/20/2020 | Merck Sharp & Dohme Corporation | ZERBAXA (Drug) | Food and Beverage | In-kind items and services | $92.18 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 02/19/2020 | Merck Sharp & Dohme Corporation | ZERBAXA (Drug) | Food and Beverage | In-kind items and services | $99.58 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 01/22/2020 | Merck Sharp & Dohme Corporation | ZERBAXA (Drug) | Travel and Lodging | In-kind items and services | $165.39 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 01/22/2020 | Merck Sharp & Dohme Corporation | ZERBAXA (Drug) | Food and Beverage | In-kind items and services | $124.99 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 12/20/2019 | Merck Sharp & Dohme Corporation | ZERBAXA (Drug) | Travel and Lodging | Cash or cash equivalent | $145.55 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 12/20/2019 | Merck Sharp & Dohme Corporation | ZERBAXA (Drug) | Travel and Lodging | Cash or cash equivalent | $107.52 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 12/16/2019 | Merck Sharp & Dohme Corporation | ZERBAXA (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,520.00 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 12/16/2019 | Merck Sharp & Dohme Corporation | ZERBAXA (Drug) | Travel and Lodging | Cash or cash equivalent | $25.00 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 12/11/2019 | Merck Sharp & Dohme Corporation | ZERBAXA (Drug) | Food and Beverage | In-kind items and services | $124.40 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 12/06/2019 | Merck Sharp & Dohme Corporation | ZERBAXA (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,520.00 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 12/06/2019 | Merck Sharp & Dohme Corporation | ZERBAXA (Drug) | Travel and Lodging | Cash or cash equivalent | $150.00 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 12/04/2019 | Merck Sharp & Dohme Corporation | ZERBAXA (Drug) | Food and Beverage | In-kind items and services | $99.60 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 11/28/2019 | Merck Sharp & Dohme Corporation | ZERBAXA (Drug) | Travel and Lodging | Cash or cash equivalent | $188.90 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 11/15/2019 | TELA Bio, Inc. | Ovitex (Device) | Consulting Fee | Cash or cash equivalent | $6,750.00 | General |
| Category: Surgical Mesh | ||||||
| 11/13/2019 | TELA Bio, Inc. | Ovitex (Device) | Travel and Lodging | In-kind items and services | $179.44 | General |
| Category: Surgical Mesh | ||||||
| 11/13/2019 | TELA Bio, Inc. | Ovitex (Device) | Travel and Lodging | In-kind items and services | $63.66 | General |
| Category: Surgical Mesh | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 6 | 332 | 827 | $389,416 | $127,609 |
| 2022 | 9 | 349 | 618 | $307,130 | $101,606 |
| 2021 | 6 | 304 | 719 | $345,476 | $122,466 |
| 2020 | 10 | 505 | 1,038 | $440,762 | $161,485 |
Total Patients
1,490
Total Services
3,202
Medicare Billing
$513,166
Procedure Codes
31
All Medicare Procedures & Services
31 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99291 | Critical care, first 30-74 minutes | Facility | 2023 | 179 | 527 | $307,241 | $99,312 | 32.3% |
| 99292 | Critical care, each additional 30 minutes | Facility | 2023 | 53 | 175 | $45,150 | $16,637 | 36.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 42 | 58 | $9,860 | $4,477 | 45.4% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 16 | 19 | $5,985 | $2,940 | 49.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 21 | 27 | $6,480 | $2,726 | 42.1% |
| 36556 | Insertion of non-tunneled central venous tube for infusion (5 years or older) | Facility | 2023 | 21 | 21 | $14,700 | $1,516 | 10.3% |
| 99291 | Critical care, first 30-74 minutes | Facility | 2022 | 160 | 371 | $216,293 | $72,260 | 33.4% |
| 49566 | Repair of trapped recurrent incisional or abdominal hernia | Facility | 2022 | 11 | 12 | $30,432 | $7,575 | 24.9% |
| 99292 | Critical care, each additional 30 minutes | Facility | 2022 | 38 | 67 | $17,028 | $6,583 | 38.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 51 | 71 | $12,070 | $5,487 | 45.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 34 | 40 | $9,600 | $4,764 | 49.6% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 13 | 13 | $4,550 | $1,977 | 43.5% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 17 | 17 | $4,403 | $1,413 | 32.1% |
| 36556 | Insertion of non-tunneled central venous tube for infusion (5 years or older) | Facility | 2022 | 13 | 13 | $9,100 | $992.53 | 10.9% |
| 36620 | Insertion of artery tube for blood sampling or infusion through skin | Facility | 2022 | 12 | 14 | $3,654 | $554.12 | 15.2% |
| 99291 | Critical care delivery critically ill or injured patient, first 30-74 minutes | Facility | 2021 | 176 | 533 | $297,340 | $105,929 | 35.6% |
| 99292 | Critical care delivery critically ill or injured patient | Facility | 2021 | 43 | 83 | $20,742 | $8,329 | 40.2% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 44 | 58 | $9,860 | $4,477 | 45.4% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 14 | 17 | $4,080 | $2,079 | 51.0% |
| 36556 | Insertion of central venous catheter for infusion, patient 5 years or older, not tunneled | Facility | 2021 | 14 | 14 | $9,800 | $1,087 | 11.1% |
| 36620 | Insertion of arterial catheter for blood sampling or infusion, accessed through the skin | Facility | 2021 | 13 | 14 | $3,654 | $563.78 | 15.4% |
| 99291 | Critical care delivery critically ill or injured patient, first 30-74 minutes | Facility | 2020 | 264 | 673 | $347,268 | $132,097 | 38.0% |
| 99292 | Critical care delivery critically ill or injured patient | Facility | 2020 | 54 | 91 | $21,840 | $9,194 | 42.1% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 46 | 68 | $11,560 | $4,391 | 38.0% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2020 | 22 | 66 | $11,550 | $4,319 | 37.4% |
About Dr. Bruce Abell, MD
Dr. Bruce Abell, MD is a Surgery healthcare provider based in Washington, District of Columbia. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 02/09/2006. The National Provider Identifier (NPI) number assigned to this provider is 1801869896.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Bruce Abell, MD has received a total of $94,671 in payments from pharmaceutical and medical device companies, with $30.43 received in 2021. These payments were reported across 107 transactions from 6 companies. The most common payment nature is "Consulting Fee" ($44,548).
As a Medicare-enrolled provider, Abell has provided services to 1,490 Medicare beneficiaries, totaling 3,202 services with total Medicare billing of $513,166. Data is available for 4 years (2020–2023), covering 31 distinct procedure/service records.
Ad
Practice Information
- Specialty Surgery
- Location Washington, DC
- Active Since 02/09/2006
- Last Updated 07/08/2007
- Taxonomy Code 208600000X
- Entity Type Individual
- NPI Number 1801869896
Products in Payments
- Ovitex (Device) $50,071
- ZERBAXA (Drug) $22,631
- GIAPREZA (Drug) $19,140
- ENTEREG (Drug) $2,714
- SURGIMEND (Device) $53.64
- Da Vinci Surgical System (Device) $25.00
- STRATTICE (Device) $21.10
- BRIDION (Drug) $14.85
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Surgery Doctors in Washington
Dr. Christian Shults, Md, MD
Surgery — Payments: $389,156
Surgery $389,156
Jonathan Johnson, M.d, M.D
Surgery — Payments: $380,629
Surgery $380,629
Parag Bhanot, Md, MD
Surgery — Payments: $168,801
Surgery $168,801
Dr. Frederick Brody, Md, MD
Surgery — Payments: $98,954
Surgery $98,954
Jeffrey Shupp, Md, MD
Surgery — Payments: $57,789
Surgery $57,789
Dr. Brandon Tauberg, M.d, M.D
Surgery — Payments: $52,430
Surgery $52,430